Investor Relations

IR Home

IR Home

Recent News
11/30/22
BILLERICA, Mass. , Nov. 30, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received a letter from the Listing Qualifications Department of The NASDAQ Stock Market (“NASDAQ”) on November 25, 2022 notifying Conformis that, based on the closing bid price of Conformis’
11/29/22
First Actera™ procedure underscores company’s ongoing commitment to advancing joint replacement technology by leveraging its data-driven approach and surgical planning expertise BILLERICA, Mass. , Nov. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that
Upcoming Events
More events are coming soon.
IR Contact  
Investor Relations
Phone: (781) 374-5598
E-mail: ir@conformis.com